Month: September 2020

CARGOTEC CORPORATION, STOCK EXCHANGE RELEASE, 15 SEPTEMBER 2020 AT 9:30 AM (EEST)Cargotec’s third quarter 2020 better than expected: Cargotec estimates orders received and comparable operating profit to increase compared to the second quarter 2020Cargotec updates its business development estimate published on 17 July 2020 and gives guidance for the third quarter 2020. Cargotec’s business development has continued well during July-August. Cargotec estimates orders received (Q2/2020: EUR 637 million) and comparable operating profit (Q2/2020: EUR 43.4 million) to increase compared to the second quarter 2020.In its 2020 half year financial report on 17 July 2020, Cargotec estimated that in the current exceptional situation it is not able to give guidance for the year 2020. Cargotec then estimated that during the second half of the year, its...

CARGOTEC OYJ, PÖRSSITIEDOTE, 15. SYYSKUUTA 2020 KLO 9.30Cargotecin vuoden 2020 kolmas neljännes ennakoitua parempi: Cargotec arvioi saatujen tilausten ja vertailukelpoisen liikevoiton nousevan vuoden 2020 toiseen vuosineljännekseen verrattunaCargotec päivittää 17.7.2020 julkistettua arviota liiketoiminnan kehityksestä ja antaa tulosohjeistuksen vuoden 2020 kolmannelle vuosineljännekselle. Yhtiön liiketoiminnan kehitys on jatkunut heinä-elokuussa hyvänä. Cargotec arvioi saatujen tilausten (Q2/2020: 637 miljoonaa euroa), ja vertailukelpoisen liikevoiton (Q2/2020: 43,4 miljoonaa euroa) nousevan verrattuna vuoden 2020 toiseen neljännekseen.Tammi-kesäkuun 2020 puolivuosikatsauksessaan 17. heinäkuuta 2020 Cargotec arvioi, ettei yhtiö kykene vallinneissa poikkeusolosuhteissa antamaan tulosohjeistusta, vaan arvioi sen liiketoiminnan ja markkinaympäristön...

Lochem, 15 September 2020By 2025 an underlying EBITDA between €125 million and €135 million1, as a result of both like-for-like growth and acquisitions (2019: €88.5 million and H1 2020: €48.2 million);Annual growth (like-for-like, i.e. excluding acquisitions) of underlying EBITDA by 0%-3%1 (as of 2020) in the challenging home countries;Operational costs at least €10 million lower in 2025 compared to 2020;A dividend policy, with a distribution of 40%-60% (was 40%-50%) of underlying net profit (after tax). 1 At constant currenciesBuild to Grow 2025: customer focused, innovative, efficient and sustainable As the leading feed company in Europe, ForFarmers is an important link in the value chain that supplies food, including animal protein, to the growing global population. However, with the exception of Poland, the agricultural sector is...

Lochem, 15 september 2020ForFarmers maakt strategie 2025 bekend              Veerkrachtig in uitdagende thuismarkten, uitbreiding naar nieuwe landen   ForFarmers N.V. (ForFarmers/de onderneming) introduceert vandaag tijdens een Capital Markets Day de strategie ‘Build to Grow 2025’ aan analisten en beleggers. De onderneming richt zich in de komende vijf jaar op het verder uitbouwen van de marktposities in de bestaande thuismarkten, door het leveren van innovatieve voederconcepten, die veehouders helpen op een duurzame manier een optimaal rendement op het boerenerf te halen. Hiervoor wordt onder meer zwaarder ingezet op digitalisering van bedrijfsprocessen, zowel op het boerenerf als bij ForFarmers. Daarnaast ambieert ForFarmers te groeien door overnames in bestaande markten en in nieuwe groeimarkten, eventueel buiten Europa. De doelstelling...

LONDON and VANCOUVER, British Columbia, Sept. 15, 2020 (GLOBE NEWSWIRE) — Mkango Resources Ltd. (AIM/TSX-V: MKA) (the “Company” or “Mkango”) is pleased to announce the results of a reconnaissance shallow soil sampling and auger programme in its 869 square kilometre (“sq km”) Mchinji licence (EPL 0544/19) in Mchinji district, Malawi, held by Mkango’s 100% owned subsidiary MKA Exploration Ltd.(see map https://mkango.ca/site/assets/files/4775/20200914_mchinji_sampling_on_topo.jpg)The results demonstrate the presence of interesting grades of rutile plus anatase (both naturally occurring mineral forms of titanium dioxide: TiO2) mineralisation of up to 1.07%, with overall TiO2 grades in the range 0.51 to 4.10% in auger samples and 0.14–2.38% in soil samples; also ilmenite grades of 1.30 to 3.40% (average 1.85%)...

Mr. Steve Muehler, Founder & President of Private Placement Markets, today announced the firm would be opening division of the Firm to focus solely on the Aviation & Aerospace Markets. According to a statement released by Mr. Steve Muehler, Founder & Senior Managing Member of the Private Placement Markets, “Opportunity Zones were enacted as part of the 2017 Tax Reform Package to increase investments and improve economic recovery in distressed areas of the United States. Opportunity Zones are set geographic areas within the United States identified by Governors as economically distressed based on census data.” “The Community benefit of an Opportunity Zone program is the incentive it provides for increased investment in business and property in distressed areas. The benefit to the investor is the deferral or elimination of...

 Les Ulis, le 15 septembre 2020Lexibook présente Trio Max, l’écran nomade révolutionnaire pour ordinateur portableLexibook annonce le lancement de Trio Max, un écran additionnel polyvalent pour ordinateur portable.Trio Max est un écran nomade de 14 pouces qui se magnétise et se glisse simplement à l’arrière de tout ordinateur portable de 13 à 17 pouces pour créer une expérience double-écran. Conçu pour ceux qui souhaitent travailler et jouer dans un confort optimal, il révolutionne le travail et la productivité à distance. Selon une recherche menée par McKinsey, un deuxième écran peut augmenter la productivité jusqu’à 50%.Trio Max dispose d’un affichage IPS 1080p économe en énergie et avec luminosité réglable. Il offre une excellente ergonomie grâce à sa légèreté, un angle de vue flexible et des utilisations en modes paysage...

Funding for COVID-19 research and development program (K-NK-ID101), to investigate the potential to establish it as a universal countermeasure to fight COVID-19 and future pandemicsFunding obtained from the Advanced Regenerative Manufacturing Institute’s BioFabUSA program, in partnership with the United States Department of Defense (DoD)Provides foundation for evaluating K-NK-ID101 as a protection for immunocompromised and high-risk patients against multiple seasonal respiratory infections, including influenza and RSV, either alone or in combination with vaccines and antibodiesAmsterdam, The Netherlands, September 15, 2020 – Kiadis Pharma N.V. (“Kiadis” or the “Company”) (Euronext Amsterdam and Brussels: KDS), a clinical stage biopharmaceutical company developing innovative NK-cell-based medicines for the treatment of life-threatening...

Schlieren/Switzerland, 15 September 2020The news release can be downloaded from the following link:AttachmentRelease